LBPH Live signals | Maximize Profits with Getagraph.com

BUY 100299 min ago

@ $20.40

Issued: 14 Feb 2024 @ 12:18

Return: -0.64%

Previous signal: Feb 13 - 15:23

Previous signal: Sell

Return: 0.94 %

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 16:00):

Stats
Today's Volume	497 564
Average Volume	591 369
Market Cap	730.07M
EPS	$-0.620 ( 2024-03-14 )
Next earnings date	( $-0.600 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.48
ATR14	$0.0570 (0.28%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-08	Kaye Randall	Buy	107 560	Stock Option (Right to Buy)
2024-02-08	Kaye Randall	Buy	17 920	Common Stock
2024-02-08	Roberts Brandi	Buy	90 580	Stock Option (Right to Buy)
2024-02-08	Roberts Brandi	Buy	15 090	Common Stock
2024-02-08	Lind Kevin Robert	Buy	332 134	Stock Option (Right to Buy)

INSIDER POWER
-62.75
Last 48 transactions
Buy: 2 180 330 \| Sell: 4 964 362

Volume Correlation

Long: -0.34 (neutral)

Short: 0.23 (neutral)

Signal:(47.35) Neutral

Longboard Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Longboard Correlation - Currency/Commodity

0.52
( weak )

0.54
( weak )

0.00
( neutral )

0.27
( neutral )

0.64
( weak )

0.28
( neutral )

Longboard Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-5 000.00 (0.00 %)
EPS:	$-2.39

Q4	2023
Revenue:	$0
Gross Profit:	$-1 000.00 (0.00 %)
EPS:	$-0.630

Q3	2023
Revenue:	$0
Gross Profit:	$-1 000.00 (0.00 %)
EPS:	$-0.550

Q2	2023
Revenue:	$0
Gross Profit:	$-2 000.00 (0.00 %)
EPS:	$-0.650

Financial Reports:

No articles found.

Longboard

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.